View in EDS

Low-dose belimumab reduced risk of flares in patients with systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: Low-dose belimumab reduced risk of flares in patients with systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial.
Authors: Sun F; Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China., Wang H; Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China., Zhang D; Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China., Shen N; Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China., Chen S; Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China., Li T; Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China., Wan W; Department of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China., Dai SM; Department of Rheumatology and Immunology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China., Ye S; Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Electronic address: ye_shuang2000@163.com.
Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2026 Mar; Vol. 85 (3), pp. 489-496. Date of Electronic Publication: 2025 Nov 06.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-2060
DOI:10.1016/j.ard.2025.10.010